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Experimental autoimmune encephalomyelitis (EAE) is a polygenic chronic inflammatory demyelinating dis-
ease of the nervous system, commonly used as an animal model of multiple sclerosis. Previous studies
have identified multiple quantitative trait loci (QTLs) controlling different aspects of disease pathogenesis.
However, direct genetic control of cortical motor evoked potentials (cMEPs) as a straightforward measure
of extent of demyelination or synaptic block has not been investigated earlier. Here, we examined the genetic
control of different traits of EAE in a F2 intercross population generated from the EAE susceptible SJL/J (SJL)
and the EAE resistant C57BL/10.S (B10.S) mouse strains involving 400 animals. The genotypes of 150 micro-
satellite markers were determined in each animal and correlated to phenotypic data of onset and severity of
disease, cell infiltration and cMEPs. Nine QTLs were identified. Three sex-linked QTLs mapped to chromo-
somes 2, 10 and 18 linked to disease severity in females, whereas QTLs on chromosomes 1, 8 and 15
linked to the latency of the cMEPs. QTLs affecting T-lymphocyte, B-lymphocyte and microglia infiltration
mapped on chromosomes 8 and 15. The cMEP-associated QTLs correlated with incidence, onset or severity
of disease, e.g. QTL on chromosome 8, 32–48 cM (EAE 31) (LOD 6.9, P < 0.001), associated to cMEP latencies
in non-immunized mice and correlated with disease onset and EAE 32 on chromosome 15 linked to cMEP
latencies 15 days post-immunization and correlated with disease severity. Additionally, applying tissue
microarray technology, we identified QTLs associated to microglia and lymphocytes infiltration on chromo-
somes 8 and 15, which are different from the QTLs controlling cMEP latencies. There were no alterations in
the morphological appearance of the myelin sheaths. Our findings suggest a possible role of myelin compo-
sition and/or synaptic transmission in susceptibility to EAE.
INTRODUCTION
Multiple sclerosis (MS) is a complex polygenic disease with
prevalence dependent on age, gender and hormonal and
environmental factors. Susceptibility to MS is influenced by
genetic factors, as indicated by numerous studies showing
higher rates of disease concordance in monozygotic than in
dizygotic twins, and higher incidence in the offspring of MS
patients (1,2). The primary genetic contribution to MS suscep-
tibility is thought to be linked to the HLA locus (1). Identifi-
cation of the non-MHC genetic loci regulating MS is a
complex task due to genetic heterogeneity, incomplete
penetrance and influence of environmental factors (3,4).
Hence, genetic analysis of well-defined experimental models
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such as experimental autoimmune encephalomyelitis (EAE)
and the search of syntenic regions between different species
in these susceptible loci (5) have the potential to accelerate
the genetic analysis of MS (6). In animals and humans, most
studies indicate that both non-MHC genes and MHC genes
are associated with the susceptibility to EAE (7). The first
quantitative trait loci (QTL) identified, EAE1, is located on
chromosome 17 and includes the MHC. Nevertheless, inbred
strains sharing the same MHC haplotype vary in their suscep-
tibility, indicating the existence of non-MHC susceptibility
genes. The conservative estimate for the number of non-
MHC susceptibility genes involved is suggested to be more
than 30 (8–10). In the past few years, extensive search loca-
lized 28 QTLs that regulate EAE in mice, mostly in crosses
involving the SJL/J and C57BL/10.S strains, both sharing
the same H2 haplotype (11).
We assumed that there could be additional QTLs that con-
tribute to the susceptibility to EAE by controlling disease
pathways that have not yet been identified. So we set out to
identify such QTLs in a new wide genome screen of the F2
generation between C57BL/10.S and SJL/J strains. We
focused on functional parameters of the central nervous
system (CNS) of EAE mice as a primary trait. Impaired func-
tion reflected in electrophysiological changes was shown to be
associated with disease severity and demyelination in earlier
studies (12). The deterioration of the myelin sheath is one of
the main pathological characteristics during the disease, and
temporal dispersion of neuronal conduction due to demyelina-
tion can result in altered cortical evoked responses. Cortical
motor evoked potentials (cMEP) provide quantitative data
on the physiological status of myelinated cortical motor
neuron projections and synaptic transmission and are thus par-
ticularly appropriate for a functional study of the descending
tracts. With the measurement of latencies of cMEP, additional
features such as cell infiltration in the spinal cord, demyelina-
tion and axonal damage by implementing tissue microarrays
(TMAs) of spinal cord cylinders, disease onset and severity
were performed. In this study, we report the identification of
nine QTLs controlling disease severity, cellular infiltration
and latencies of cMEPs.
RESULTS
EAE incidence and severity in (SJL/J-C57Bl/10S)
F2 progeny
We generated a total number of 42 (SJL/J  C57BL/10.S) F1
and 400 (SJL/J  C57BL/10.S) F2 mice and immunized all of
them. In the F1 progeny (SJL/J  C57BL/10.S), 82.8% (33
out of 42 animals) developed EAE, with a mean disease sever-
ity score of 2.75+ 1.26 and a mean duration until onset of
13.04+ 2.18 days. More females were affected (93.3%; 14
out of 15) than males (70.3%; 19 out of 27). The (SJL/
J  C57BL/10.S) F2 animals had an incidence of 58.6%
(248 out of 400), with a mean disease severity score of
2.69+ 1.27 and a mean delay of onset of 12.98+ 3.22
days post-immunization. Again, more females were affected
(74.6%; 154 out of 207) than males (48.4%; 94 out of 193).
This is consistent with published studies (10).
QTL associated with disease onset, severity
and cell infiltration
We genotyped all F2 mice for linkage analysis, as described in
Materials and Methods, and we phenotyped for the latencies of
cMEP and cell infiltration in spinal cord, as well as disease
onset and severity.
In the initial screen, we identified three QTLs controlling
disease severity in females located on chromosomes 2, 10
and 18 (Table 1; Fig. 1). The first locus (EAE 33) on chromo-
some 2 had significant evidence of linkage to marker D2Mit32
(LOD score of 3.7). The second locus (EAE 34) on chromo-
some 10 was significantly linked to marker D10Mit261
(LOD score of 3.8). On chromosome 18, suggestive linkage
to D18Mit144 was found (LOD score of 3.2). A QTL control-
ling disease onset in females on chromosome 10 with a peak
linkage to a D10Mit271 was also identified (LOD score of
3.7). This locus overlaps with the severity controlling locus,
EAE 34.
Additionally, we identified a suggestive QTL (EAE 38)
associated to disease severity in males [linked to area under
the curve (AUC) as a trait] on chromosome 15 (linked to
D15Mit171, LOD score of 3.3).
Using TMAs and immunohistochemical stains for amyloid
precursor protein (APP), myelin basic protein (MBP), neurofi-
lament (NF200) and conventional Luxol–Nissl stain of spinal
cords cylinders revealed no significant difference in the mye-
lination pattern and axonal integrity, thus pointing towards a
minor involvement of obvious demyelination at this stage of
disease. However, the stains for microglia (IBA1) and B-
and T-lymphocytes (B220 and CD3) revealed differences
between the individual animals (Fig. 2). Two new QTLs
related to the amount of infiltrating T-lymphocytes and micro-
glia (Table 1; Fig. 3) were identified on chromosome 8 (EAE
36, linked to D8Mit259) and on chromosome 15 (EAE 37,
linked to D15Mit35), respectively. A suggestive QTL associ-
ated to B-lymphocyte infiltration also map on chromosome 15
(EAE 38, linked to D15Mit171) in a region associated to
severity in males.
To validate the loci, a two-point analysis (F-statistics,
ANOVA) was performed (Supplementary Material, Table S2).
QTL associated with latencies of cMEP
In the light of the mismatch between severity and demyelina-
tion in the beginning of the disease, we sought to determine a
direct functional measure as provided by cMEP.
The cMEP consists of a biphasic wave following the stimu-
lus at a mean latency of 2.66 ms for fore limb and 3.95 ms for
hind limb (Table 2). Interestingly, we observed differences in
cMEP latencies between non-immunized parental strains
(Table 2, P , 0.05), indicating that susceptible mice already
have greater latencies in both hind limb and fore limb.
There was a considerable prolongation of latencies (Table 2;
Fig. 4) following disease induction in the F2 generation. A
representative comparison between cMEP measured in a
sick mouse at different time points during the disease is
shown in Figure 4. As obvious, disease progression leads to
a progressive delay in the cMEP onset accompanied by a
scattering of the cMEP.
1978 Human Molecular Genetics, 2005, Vol. 14, No. 14
We choose the latency of cMEP as a trait because it
appeared to be the most reproducible and reliable parameter
for both myelin disturbance and functional impairment. By
doing this, we identified three EAE loci associated to this
trait (Table 1; Fig. 1). A suggestive evidence of linkage on
chromosome 1 (EAE 30) to marker D1Mit303 associated to
the latency of cMEP 15 days after immunization (latency at
day 15 recorded in the fore limb, LOD score of 3.4). The
linkage became statistically significant only when severity as
a covariance was used in the analysis (LOD 3.7, Fig. 1E).
A linkage on chromosome 8 (EAE 31) showed a high
significance (peak marker D8Mit178, LOD score of 6.99).
Surprisingly, the locus influenced the latency of cMEP in
the fore limb before immunization. A third locus on chromo-
some 15 (marker D15Mit67, LOD score 4.5), identified as
EAE 32, influenced the latency of cMEP 15 days after immu-
nization. In this case, we use the difference in the latencies
between days 0 (before immunization) and 15 as a trait and
we recorded the cMEP in the hind limb. The same locus
linked to disease severity in males.
Table 1.Summary of the EAE linked quantitative trait loci identified in this study
QTL Chromosome Flanking
markers
Effect
marker
Allele Peak
(cM)
CI
(cM)
LOD
score
LOD score
(s-level,
P ¼ 0.05)
Trait References
EAE30 1 D1Mit380
D1Mit236
D1Mit303a SJL/J 22 11–32 3.4a
4.7b
3.9c
3.5
4.7b
3.7c
Forelimb cMEP
latency day 15
New, overlaps
with Idd5 locus
in diabetes,
Greve et al. (16)
EAE31 8 D8Mit24
D8Mit88
D8Mit258
D8Mit259
D8Mit178
D8Mit15
SJL/J 42 32–48 6.9 3.7 Forelimb cMEP
latency day 0
New
EAE32 15 D15Mit126
D15Mit35
D15Mit67
D15Mit171
C57BL/10.S 38 24–56 4.5
6.1b
3.8
5.6b
Hindlimb cMEP
latency,
difference
day 15–day 0
New
EAE33 2 D2Mit11 D2Mit32 C57BL/10.S 20 6–30 3.7 3.6 Severity females New
D2Mit372
EAE34 10
10
D10Mit2
D10Mit233
D10Mit233
D10Mit271
C57BL/10.S
C57BL/10.S
56
59
42–58
52–58
3.8
3.7
3.6
3.5
Severity females
Onset females
New, partially
overlaps with
EAE17,
Blankenhorn
et al. (17)
EAE35 18 D18Mit186.1 D18Mit144.1a C57BL/10.S 68 54–69 3.26a 3.6 Severity females Overlaps with
EAE25,
Blankenhorn
et al. (17)
EAE36 8 D8Mit124
D8Mit178
D8Mit258
D8Mit259
SJL/J 26 2–34 4.1 3.6 T-lymphocytes
infiltration in
spinal cord
Overlaps with
EAE14,
Blankenhorn
et al. (17)
EAE37 15 D15Mit171 D15Mit35 C57BL/10.S 69 58–69 3.6 3.5 Microglia
infiltration
in spinal cord
New
EAE38 15 D15Mit67.1
D15Mit35
D15Mit171a C57BL/10.S
C57BL/10.S
54
56
18–72
46–68
3.3a
3.3a
3.6
3.5
AUC males
B-lymphocytes
infiltration in
spinal cord
New
CI, Confidence intervals; LOD score s-level, significance level 95% (threshold values calculated based on 1000 permutations).
aSuggestive locus.
bSex influence.
cSeverity influence.
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Figure 1. QTL identified in this study. QTL graphics showing the linkage between the different traits and the corresponding microsatellite marker. LOD
score values represent the values for which each association became statistically significant (A) EAE 33 QTL associated to disease severity in females.
(B) EAE 34 QTL linked to disease onset in females. (C) EAE 32 QTL associated to latency of cMEP in hind limb (HLCMEP) 15 days after immunization
[trait study as a difference (D) between the latency at day 15 and the latency at day 0 for each mouse]. (D) EAE 31 QTL associated to latency of cMEP
measured in the fore limb (FLCMEP) before immunization (day 0). (E) EAE 30 QTL associated to latency of cMEP measured in the fore limb 15 days
post–immunization. Full lines represent the association graphic, whereas segment lines represent the association graphic using the severity as a covariant.
(F) EAE 37 QTL linked to microglia infiltration in spinal cord. (G) EAE 36 QTL linked to T-cell infiltration in spinal cord.
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There is no overlap between QTL controlling histo-
pathological changes and QTL controlling cMEP latencies.
A decrease of the incidence in mice used for the electro-
physiology (42%) when compared with the rest of F2
mice (58 %) was observed (x2 ¼ 15.01 . 3.84) but disease
severity and onset were not affected by the neurological
procedure. The mean disease severity score in mice for
electrophysiology was 2.72+ 1.50, which did not differ
from the whole group, 2.67+ 1.29 (P ¼ 0.8). The mean
onset values in the electrophysiological group and the whole
group were 13.31+ 3.19 and 12.98+ 3.22 days, respectively
(P ¼ 0.8). To validate the loci, a two-point analysis
(F-statistics, ANOVA) was performed (Supplementary
Material, Table S2).
Association and correlation between QTLs influencing
cMEP and incidence, disease onset, disease severity
and cell infiltration
To explore the relevance of cMEP controlling alleles, we
investigated their effect, i.e. their relationship to incidence
onset and severity of disease, as well as to cell infiltration.
EAE 30 influenced the latency of cMEP at day 15 as recorded
in the fore limb and was associated to the incidence of the
disease because sick mice at day 15 showed longer conduction
times than healthy mice (P ¼ 0.02) (Tables 3 and 4, Sup-
plementary Material, Table S1 and Supplementary Material,
Fig. S1). Additionally, mice with severe disease had longer
latencies than healthy mice (P ¼ 0.009). When we divided
Figure 2. Morphological analysis of spinal cord cylinders arranged in TMAs. Subset a. (A) Hematoxilin–eosin stain (H&E) of a representative spinal cord
cylinder of 1.3 mm diameter. (B) B-lymphocytes infiltration (B220, 20  ). (C) T-lymphocytes infiltration (CD3, 20). (D–F). Low microglia infiltration
(IBA-1). (G–I). High microglia infiltration (IBA-1) [magnifications (D and E) 1; (E and F) 5; (F), I 40]. Subset b. Myelination properties is represented
in (A and B) and stain of the MBP and number of axons in (C and D). Neurofilament (NF200) axonal stain [magnifications (A and B) 1; (B and D) 10; left
white matter, right gray matter]. Myelin and axonal stains revealed no significant individual differences between the mice.
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the mice in groups, depending on their alleles at this locus, it
was evident that the SJL allele is the major contributor to this
association. In this case, mice with both mild and severe
disease show differences with respect to healthy mice
(P ¼ 0.036 and P , 0.001, respectively). Furthermore, mice
with the SJL allele at this locus, with B-lymphocyte infiltration
in their spinal cords show slower conduction times than mice
without infiltration (P , 0.001) (Supplementary Material,
Fig. S2). EAE 31 linked to the fore limb cortical motor
evoked potential (FLCMEP) latencies before immunization.
This is reflected in the significant differences between the
B10S and the SJL (D8Mit178) mice (P , 0.001). Mice with
the SJL allele had longer latencies than mice with the B10S
allele. Early onset associates with longer latencies
(P ¼ 0.018). However, there was no association between the
latencies before immunization and the incidence or severity
of the disease.
EAE 32 linked to the latency of cMEP in the hind limb was
assessed by using the difference between the latencies at days
0 and 15 as a phenotype. The association of this trait with inci-
dence of disease was very strong (P , 0.001) and was inde-
pendent of the allele carried by the mice (Tables 3 and 4).
We also observed differences in the latencies of cMEP
between healthy mice with respect to mice suffering from
mild disease and mice having severe disease (Table 4).
There is an association with severity showing that mice with
severe disease had longer conduction times than mice present-
ing mild symptoms (P ¼ 0.006). Regression analysis (Table 3)
showed a good correlation between disease severity in mice
with the B10S allele in this locus and latency of cMEP
(R ¼ 0.87 for B10S allele homozygous mice and R ¼ 0.77
for mice with at least one copy of the B10S allele). There is
also an association with B-lymphocyte infiltration in spinal
cords because the mice with infiltration showed slower con-
duction times (measured as a difference between day 0 and
day 15) than mice without infiltration. Again, mice with at
least one copy of the B10S allele at D15Mit67 locus and
B-lymphocytes infiltration have longer conduction times
than mice without B-lymphocyte infiltration (Supplementary
Material, Fig. S2).
DISCUSSION
The most important finding of this study is the identification of
three new QTLs controlling the latency of cMEPs, a pheno-
type that functionally reflects the disease activity and provides
quantitative data additional to the semi-quantitative clinical
severity data.
EAE 30 on chromosome 1, 11–32 cM, controlled the
latency of cMEP, as recorded in the fore limb. The linkage
was disease dependent, as significance was detected when
using disease as a covariate in the analysis. This is concordant
Figure 2. Continued.
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with the observation that the latency of FLCMEP was
enhanced in diseased mice when compared with healthy
mice, with the SJL/J allele as the contributing allele. EAE
30 partially overlaps with an earlier described locus (Tmevd
6), which controls severity in Theiler’s murine encephalomye-
litis, a virus-induced demyelinating disease (12–14). It also
overlaps with the Idd5a locus identified in the NOD mice as
pre-disposing to diabetes (15), where there is strong evidence
that CTLA4 and/or ICOS (16) are the likely susceptibility
gene for this locus.
EAE 31 locus on chromosome 8, 32–48 cM, controlled the
latency of cMEPs before immunization. As shown for the
EAE 30, the contributing allele originated from the susceptible
strain, SJL/J, and had a dominant effect. A longer latency of
Figure 3. Comparison between published EAE loci and those QTL identified in this study. Red lines correspond to the 28 QTL described in the literature while
green lines represent the QTL described in our study.
Table 2. Comparison of cMEP latencies between parental strains and F2 generation
Strain Days post-
inoculation
All mice
fore limb (ms)
All mice
hind limb (ms)
Females fore
limb (ms)
Male fore
limb (ms)
Female hind
limb (ms)
Male hind
limb (ms)
Parental
C57BL/10.S 0 2.57a+ 0.17 3.90a+ 0.14
SJL/J 0 2.71a+ 0.12 4.03a+ 0.14
F2 generation
(SJL/J  C57BL/10.S)
0 2.66b,c+ 0.27 3.96b,c+ 0.29 2.63b,c+ 0.28 2.72b,c+ 0.24 3.88b,c+ 0.54 4.01b,c+ 0.27
10 2.92b+ 0.32 4.13b,d+ 0.43 2.91b+ 0.33 2.94b+ 0.32 4.01b,d+ 0.57 4.27b+ 0.60
15 3.00c+ 0.34 4.26c,d+ 1.29 2.95c+ 0.32 3.09c+ 0.38 4.26c,d+ 0.67 4.55c+ 1.26
Difference
days 10 and 0
0.27e+ 0.29 0.16e+ 0.46 0.27+ 0.31 0.23+ 0.26 0.11e+ 0.32 0.28+ 0.68
Difference
days 15 and 0
0.37e+ 0.34 0.41e+ 0.89 0.36+ 0.32 0.39+ 0.41 0.33e+ 0.69 0.59+ 1.33
Values are given as mean+ SD.
aSignificant differences between the strains, P, 0.05.
bSignificant differences between days 0 and 10 post-immunization, P, 0.05.
cSignificant differences between days 0 and 15 post-immunization, P, 0.05.
dSignificant differences between days 10 and 15 post-immunization, P, 0.05.
eSignificant differences between latencies (days 10–day 0) and latencies (days 15–day 0), P, 0.05.
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cMEPs (measured in the fore limb) before immunization also
correlates significantly with an earlier onset of the disease
(P , 0.001). This suggests that at least one gene affecting
axon structure, myelin composition or synapse transmission
may pre-dispose susceptible mice to an early onset of the
disease. EAE 31 partially overlaps with the EAE 14 locus pre-
viously linked to the incidence (9) of the disease and to
demyelination (17). EAE 31 maps to a region that also con-
tains several genes of putative relevance. One of those
genes, the calcium channel alpha1 subunit gene
(CACNA1a), encodes the alpha subunit of a P-type calcium
channel (18–20). CACNA1a is associated with neurological
symptoms in mice, like ataxia. Furthermore, it is polymorphic
and earlier studies show that it is differentially expressed
during the course of EAE (21). Another interesting but less
likely contributing gene, Caspase 3, is involved in apoptotic
death of different neuronal cells (22–24) where apoptosis is
one of the pathways that leads to demyelination (25). Genes
like the Janus kinase 3 (JAK3) and carboxypeptidase E
(CPE) are also putative contributors, although these genes
cannot be linked to the phenotype studied. However, both
genes mapped to this interval are differentially expressed
during the disease (26) and are polymorphic genes (27–30).
CPE is a secretory granule enzyme involved in dibasic
cleavage of pro-proteins and pro-hormones (31), whereas
JAK3 is a tyrosine kinase involved in signal transduction pro-
cesses (32).
The association between the susceptibility allele on
chromosome 8 with a slower conduction and with an earlier
onset of disease could have an important meaning because
such a predictive allele could be used to screen populations
at high risk of developing MS by the non-invasive evoked
potential measurements. This finding is supported by the
fact that parental strain differences in cMEP latencies are
already observed before immunization and are likely to be
related to different myelin composition. Animals with attenu-
ated biochemical properties of the myelin sheath may, there-
fore, be more prone to develop early EAE. The differences
in cMEP measurements could unravel patients that show
distinct alteration of the myelin sheath, and it might, there-
fore, be a tool for either treatment monitoring or even risk
assessment.
EAE 32 on chromosome 15 controlled the latency of cMEPs
measured in the hind limb (LOD score 4.5). Interestingly, the
Figure 4. CMEP latencies—changes during the course of disease. Representative traces of cMEP recorded in (A) the hind limb and (B) the fore limb before
immunization (gray), 10 days (red) and 15 days post-immunization (green) in a sick mouse. CMEP are overlayed for clarity. Arrows indicate the time point of
stimulation. Note the progressive increment in latencies and the decomposition with time post-immunization. (C and D). Effect of sex and disease on the fore
limb (C) and on the hind limb cMEP latencies (D). Black bars represent the mean values of the F2 male population at different time points (days 0, 10 and 15),
whereas white bars represent the mean values of the F2 female mice. Significant differences in the latencies of fore limb and hind limb cMEP were observed in
both groups, males and females, during the course of disease.
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C57BL/10.S allele was responsible for the delay of cMEPs
after 15 days and had a dominant effect. The delay of the
cMEPs correlated with the incidence disease severity and
the B-lymphocyte infiltration. A candidate gene in this locus
is the calcium channel gamma subunit gene (CACNG2),
which encodes stargazing, a transmembrane protein, which
may act as both neuronal voltage-dependent calcium channel
gamma subunit and AMPA receptor regulatory proteins
(TARPs) and is highly expressed in cerebellum, cerebral
cortex, hippocampus and thalamus. CACNG2 is differentially
expressed during EAE (21) and it has been associated
with neurological disorders (33). Another interesting gene
in this region is peripherin, an intermediate filament
protein, which is upregulated in inflammatory processes and
leads to a degeneration of motor axons in amyotrophic
lateral sclerosis (34).
Table 3. Linear regression correlation between latencies of cMEP with severity and onset
QTL Trait Locus Genotype in
locus (allele)
Severitya (R ) Onseta (R )
EAE30 Latency of fore limb cMEP D1Mit303 All mice 0.33 –
15 days post-immunization C57BL/10.S 0.19
Heterozygous 0.01
SJL/J 0.37
EAE31 Latency of fore limb cMEP D8Mit178 All mice 20.06 20.42
before immunization C57BL/10.S 20.1 20.198
Heterozygous 20.04 20.30
SJL/J 20.07 20.40
EAE32 Latency of hind limb cMEP D15Mit67 All mice 0.64 –
day 15 (day 15–day 0) C57BL/10.S 0.87
Heterozygous 0.76
SJL/J 20.17
aCorrelation.
Table 4. Association between latencies of cMEP with severity, onset and incidence of diseasea
QTL Linkage marker Effect allele Sex effect Genotypes in
locus (allele)
Disease
association
Severity association Onset association
EAE30 D1Mit303 SJL/J No All mice P ¼ 0.02 No (healthy–mild) No
P ¼ 0.009 (healthy–severe)
No (mild–severe)
C57BL/10.S No No No
Heterozygous No No No
SJL/J P, 0.001 P ¼ 0.036 (healthy–mild) No
P, 0.001 (healthy–severe)
No (mild–severe)
EAE31 D8Mit178 SJL/J No All mice No No P , 0.001
P, 0.001 Dominant (early-late)
(C57BL/10.S-SJL/J) effect C57BL/10.S No No No (early-late)
P, 0.001
(C57BL/10.S-hetero) Heterozygous No No P ¼ 0.03
P ¼ 0.05 (early-late)
(hetero-SJL/J) SJL/J No No No (early-late)
EAE32 D15Mit67 C57BL/10.S Yes All mice P, 0.001 P ¼ 0.008 (healthy–mild) No
P ¼ 0.008 Dominant P, 0.001 (healthy–severe)
effect P ¼ 0.006 (mild–severe)
(C57BL/10.S-SJL/J) C57BL/10.S P ¼ 0.05 No (healthy–mild) No
P ¼ 0.046 P, 0.001 (healthy–severe)
P ¼ 0.009 (mild–severe)
(C57BL/10.S-hetero) Heterozygous P ¼ 0.003 No (healthy–mild) No
No P, 0.001 (healthy–severe)
P ¼ 0.017 (mild–severe)
(hetero-SJL/J) SJL/J P ¼ 0.003 P ¼ 0.001 (healthy–mild)
P ¼ 0.003 (healthy–severe)
No (mild–severe)
aStatistical analysis by ANOVA.
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Our morphological analysis of the spinal cords of the
F2 population did not reveal obvious differences in the
myelination pattern, however, already minor changes in
the biochemical composition of the isolating myelin sheath
are known to influence the electrophysiological properties
of spinal cord tracts. These biochemical changes may be
explained by the inflammation produced by the cell infiltration
because our study reveals an association between the cMEP
latencies 15 days post-immunization with the B-lymphocyte
infiltration. (Supplementary Material, Fig. S2)
In addition to the cMEP QTLs, we identified new QTLs
controlling traits like disease severity, disease onset and cell
infiltration.
Two new QTLs on chromosomes 2 (D2Mit32) and
10 (D10Mit271) were associated with severity in females
(Table 1). EAE 34 is a new QTL, although it partially overlaps
with EAE 17, which has previously been shown to be associ-
ated with disease severity and spinal cord demyelination in
females (9). EAE 33 on chromosome 2 represents a new
locus that is mapped to the distal p-fragment of the chromo-
some. This appears to be a common QTL for other auto-
immune diseases e.g. collagen-induced arthritis (CIA2) (35).
There is evidence suggesting that the complement C5 is the
probable susceptibility gene in this area because many
strains showing linkage to arthritis are C5 deficient due to a
two base pair mutation. However, there are no known poly-
morphisms or mutations in the C5 gene in C57Bl/10 or SJL/
J. This observation and additional evidence from arthritis
linkage analysis studies suggest that other genes in this
locus might be involved. On chromosome 18, we identified
a suggestive QTL (EAE 35). This locus overlaps with the
EAE 25, a QTL previously described as contributing to
spinal cord lesions in EAE (17).
Onset of the disease was linked to D10Mit233, suggesting
that the same QTL may influence severity and onset of the
disease in our F2 study. Several genes of importance are
mapped in this region like interferon gamma, a determinant
factor of disease (36).
Furthermore, we describe two QTLs controlling for the
infiltration of microglia and B-lymphocytes in a distal position
on chromosome 15. The presence of both cell types is a sign of
spinal cord inflammation and both cell types probably target
myelin sheath epitopes. Recently, it was shown that microglia
contact myelin membranes before the onset of demyelination,
suggesting that this contact could lead to a later demyelination
and inflammation (37). Indeed, microglia is the major effectors
cell in the CNS, and cytokines like IFN-gamma and TNF acti-
vate microglia into migratory and phagocytic cells. However,
there is also evidence for a role of extracellular matrix proteins
as a regulator or modulator proteins of microglia activity prob-
ably by increasing the local accessibility of fibronectin due to
different pathological conditions in the CNS, like MS (38),
and this in turn induces microglia activation and expression
of integrins like alpha-4-beta1 and alpha-5-beta1 integrin
(37). Integrin alpha-5 (fibronectin receptor-alpha-5) maps at
this region on chromosome 15. The fact that this region also
associates to the severity in males supports the suggested
role of this area in the development of the disease.
In conclusion, the cMEP-associated QTLs correlated with
incidence, onset or severity of disease and did not overlap
with QTL controlling cell infiltration, suggesting a possible
role of genetic control of basic myelin composition or patterns
and synaptic structure mediated by polymorphic genes on
chromosomes 1, 8 and 15 in susceptibility to EAE. In addition,
our data provide evidence for the view that not the entire func-
tional impairment is reflected by observable morphological
changes on light or electron microscopy level but rather
strengthens the reliability of our new strategy to choose
cMEPs as a trait for QTL analysis in diseases involving
demyelination.
Further strategies must be done to confirm the role of these
genes in EAE. Search for polymorphism in the candidate
genes by sequencing, congenic or subcongenic strains
generation for fine mapping, gene expression profiling
in these QTL, comparative genomics or functional analyses
by knock-out or transgenesis are some of the strategies that
we are developing to point out the relevant genes in the
disease.
MATERIALS AND METHODS
Mice, immunization and score of the disease
The mice used in this study were obtained from the Jackson
Laboratory and were kept under standard laboratory con-
ditions. The local state’s Animal Care Committee previously
approved all experimental procedures in agreement with the
European Communities Council Directive of November 24,
1986 (86/609/EEC). We inoculate the disease according to
established protocols (7). In brief, SJL/J, C57BL/10.S, (SJL/
J  C57BL/10.S) F1 and 400 (SJL/J  C57BL/10.S) F2
mice were immunized at 8–12 weeks of age at the base of
the tail with 100 mg of PLP139-151 (American Peptide
Company, Sunnyvale, CA, USA) dissolved in water and
mixed with an equal volume (50 ml) of CFA (IFA with
4 mg/ml Mycobacterium tuberculosis; DIFCO Laboratories
Detroit, USA). 200 ng of Bordetella pertussis toxin (Sigma,
St Louis, MO, USA) was injected to each mouse on the day
of immunization and 48 h later. Mice were followed for
4 weeks post-immunization. The clinical scoring (severity)
of EAE commenced 8 days after immunization and animals
were monitored daily according to the current protocol: 0,
norma1; 1, flaccid tail; 2, waddle; 3, moderate paraparesis;
4, severe paraparesis and 5, tetraparesis. We analyzed the
severity as the maximal score observed in each individual
mouse or the AUC, a continuous trait that measures the
accumulative severity from the disease onset until the day of
sacrifice. The day of onset was also analyzed as a quantitative
trait.
CMEP recordings
We used a total of 15 mice of each parental strain (SJL/J and
C57BL/10.S) and 125 (SJL/J  C57BL/10.S) F2 mice for
electrophysiological analysis. The F2 mice were randomly
chosen and divided into five groups. Ten days after immuniz-
ation, we anesthetized the 125 F2 mice for surgery by intra-
peritoneal injection of avertin (1.7 mg/g), an anesthetic
composed of 2,2,2-tribromoethanol (Sigma) and 2-methyl-2-
butanol (Sigma). Subsequently, we placed the mice in a
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conventional stereotactic head frame and inserted two stainless
steel screws (AgnTho’s, Lidingo¨, Sweden) 1.5 mm right of
the midline and 1.5 mm behind the bregma suture, with the
tip just above the pia mater (anode) and on the nasal bone
(cathode), under sterile conditions (39). At days 0, 10 and
15 post-immunization, we anesthetized the mice and elicited
cMEP by constant current anodal square wave pulses of
150 ms duration and a frequency of 0.2 Hz applied to the
brain surface of the motor cortex by a stimulator (A320,
World Precision Instruments, Berlin, Germany) triggered by
LabView-based software (National Instruments, Austin, TX,
USA). Intensity was adjusted to 1.5 times the level inducing
threshold contraction (40). We recorded the electromyo-
graphic response by needle electrodes (Medtronic Functional
Diagnostics, Skovlunde, Denmark) positioned in the small
muscles of the fore limb and the hind limb proximal to the
elbow (12) against a reference located at the dorsum pedis
of the paw. We also placed a ground electrode subcutaneously
between stimulating and recording electrodes. Three recording
sessions were performed over a period of 15 days. Five to
10 traces for each time point and stimulation were recorded,
and the shortest onset latency of the first deflection latency
was taken as a measure of the conduction time of cMEP.
We filtered the data with a band pass between 30 Hz
and 1.3 kHz and amplified with a gain of 1 V/mV by an
EXT-10C amplifier (NPI Electronics, Tamm, Germany).
Further digitalizing (at 10 kHz) and analysis were done
using LabView-based software (National Instruments) on a
standard PC computer.
DNA isolation and genotyping
The genomic DNAs used for genotyping the mice were
isolated from a 1 cm tail clip by using standard isolation
protocols (41). We genotyped by PCR amplification all F2
generation mice. We used 150 informative microsatellite
markers covering the genome to the extent of 98% of the
genome at 10 cM inter-marker distance. The mean inter-
marker distance ranged from 5.5 to 21.5 cM for the different
chromosomes. The accuracy of our loci order and interval
maps was verified by comparing the genetic map calculated
from our data with the Mouse Genome Informatics map
(www.jax.org). The protocol for the genotyping was as
follows. Genomic DNA (20 ng) was amplified in a final
volume of 10 ml containing Hot Start Taq polymerase
(0.25 U) (QIAGEN, Hilden, Germany), primers (0.1 mM
each) (Metabion GmbH, Planegg-Martinsried, Germany),
50 mM KCl, 1 mM Tris, 2.5 mM MgCl2, 0.25 mM dNTP and
0.02 mM M13-IRD700 or M13-IRD800 (LI-COR, Inc.,
Lincoln, NE, USA). Amplification conditions were as
follows: 958C for 10 min, followed by two cycles of 948C
for 30 s, 598C for 1 min, 728C for 1 min, two cycles of
948C for 30 s, 578C for 1 min, 728C for 1 min, then another
35 cycles of 948C for 30 s, 558C for 1 min, 728C for 1 min
and a final extension at 728C for 7 min. The reactions were
performed using GeneAmp PCR System 9700 cycler
(Applied Biosystems, Inc., Foster City, CA, USA). The PCR
products were resolved on denaturing polyacrylamide gels
and were detected by using a LI-COR Model 4200L auto-
mated DNA sequencer (LI-COR). The genotypes were
scored independently by at least two people using the Saga
software supplied by LI-COR.
Morphology
Spinal cord tissue was arranged in two TMAs. TMAs were
constructed as recently described (42). Shortly, multiple
spinal cord sections of each animal were poured into a paraffin
block. Spinal cord pieces were arranged in a TMA with 200
punch holes of 1.3 mm each. Spinal cord tissue cylinders of
the mice were transferred from the initial block to the TMA
using a puncher. Sections of 4 mm thickness were then trans-
ferred to epoxyd resin covered slides and pre-incubated in
xylol for 2 h prior to the staining procedure. Slides were con-
ventional stained with a Luxol–Nissl stain to highlight
the myelin irregularities. A Ventana machine with the appro-
priate pre-treatment (0.1 M citrate or 1 mM EDTA) was used
for immunohistochemical determination of damaged and
regenerated axons, irregular myelin, demyelination and cell
infiltration. Antibodies against APP (Boehringer, Mannheim,
Germany), MBP (DAKO, Carpinteria, CA, USA), neurofila-
ment (NF200) (Sigma), IBA1 (Wako Chemicals GmbH,
Neuss, Germany), CD3 (LabVision, Freemont, CA, USA)
and B220 (CD45R) (BDBiosciences, Heidelberg, Germany)
were used. Slides were developed using the Ventana DAB
MAP kit or the DAKO iView kit.
The staining was evaluated double blind by establishing a 1
to 5 point evaluation scale for the different staining intensities
(Luxol–Nissl, APP, MBP and NF200). Staining intensity in
control spinal cords was used as a reference. The number of
CD3 and B220 positive cells was counted on a representative
spinal cord diameter of 1.3 mm.
Linkage analysis
All linkage analyses have been performed using the imputa-
tion model in the R/qtl software package (43,44). The order
of the loci was obtained from the mouse genome informatics
database of the Jackson Laboratory (http:/www.informatics.
jax.org). EAE severity and onset of the disease, latencies of
cMEP and spinal cord cell infiltration were taken as pheno-
types. Continuous values were checked for normal distribution
using QTL Cartographer Software and logarithmic values
were used when necessary. For the significant and suggestive
linkage threshold values, we have followed the guidelines for
the permutation test of data (number of permutations ¼ 1000),
and significance level 95% (P ¼ 0.05) was used to determine
linkage. Intervals containing significant evidence of linkage
were reanalyzed by using Analyse-it software (http:/www.
analyse-it.com) testing the association between marker and
phenotype using analysis of variation (ANOVA).
Statistics
Results are expressed as mean+SD or SEM where appropriate.
A P-value ,0.05 was considered significant. Linear
regression and ANOVA were used to test the correlation or
association between the latencies of cMEP and the onset,
severity incidence of the disease and cell infiltration.
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